Journal of Pharmaceutical and Biomedical Sciences

Thyroid Dysfunction in Patients with Type-2 Diabetes Mellitus in Eastern India

Saroj Mishra, Shubhankar Mishra, Bijaya Kumar Behera

Abstract


Context To study the prevalence of thyroid dysfunction in type-2 diabetics and spectrum of thyroid dysfunction in view of importance of thyroid disorders on glycemic status and complications of diabetes mellitus (DM).

Aim The aim of this study is to establish the relationship between the diabetes and thyroid dysfunction probably affected as aconsequence to the autoimmune pathology.

Settings and Design It was a case control study done in the Department of General Medicine, MKCG Medical College, a tertiary care hospital of southern Odisha.

Patients and Methods A total of 50 cases (diagnosed case of type-2 DM) and 50 healthy controls were taken in consideration randomly. Thyroid function tests were done using chemiluminescence assay. Then it was analysed statistically after tabulation.

Statistical Analysis Used Statistical analysis was done using Chi-square test for categorical variables. Student’s t-test was used for finding significance between the means. A ‘P-value of <0.05’ was considered significant.

Results Thyroid dysfunction was found to be more in type-2 DM (16%) than in healthy controls (4%) which was significant. Among those diabetic patients with thyroid dysfunction, 6 (75%) out of 8 were females. The mean BMI was high in diabetic patients with thyroid dysfunction. The HbA1c levels in patients who had thyroid dysfunction were high. Those with thyroid dysfunction had a mean total cholesterol level higher than euthyroid diabetics and controls. Goitre was found to be present in 4% of cases of type-2 DM.

Conclusion Type-2 DM and thyroid diseases have a significant association. Subclinical hypothyroidism and hypothyroidism (overt) were the commonest thyroid abnormality in type-2 DM. Thyroid dysfunction was associated with worsening dyslipidemia in type-2 DM.

 


Keywords


Type-2 DM, thyroid dysfunction, latent autoimmune diabetes of adulthood

Full Text:

References


Powers AC. Harrison’s principles of internal medicine, 19th ed., Ch 417. In: Diabetes Mellitus. The McGraw-Hill Companies, Inc. 2005. p. 2399.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the diabetes control and complications trial research group. N Engl J Med. 1993;329:977–986.

Satish R, Mohan V. Diabetes and thyroid diseases: review. Int J Diab Dev Countries. 2003;23:120–3.

Patricia Wu. Thyroid diseases and diabetes. Clin Diabetes Winter,2000;18(1):38.

Mohan V, Tripathy BB. RSSDI introducation. 2nd ed., In: RSSDI text book of diabetes mellitus. 2008. pp. 1–3.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and

Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499.

Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol. 2006;43(1):14–18.

Nobre EL, Jorge Z, Prates S, Silva C, Castro JJ. Profile of thyroid function in a population with type-2 diabetes mellitus. Br Endocr Soc. Abstract;3:298

Krejci H, Perusicova J. Autoimmune thyropathies in patients with diabetes mellitus type 1 and 2. DMEV. 2004;7:164.

Tunbridge WMG, Evered DC, Hall R. The spectrum of thyroid disease in community: the Whickham survey. Clin Endocrinol. 1977;7(6):481–93.

Smithson MJ. Screening for thyroid dysfunction in a community population of diabetes patients. Diabet Med. 1998;15(2):148–50.

Kenigsberg S. Pharmalogical approaches to treating obese patient. Clin Endocrinol Metab. 1976;5(2):455–79.

Schleinger JL, Anceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the level of circulating thyroid hormones. Diabetologia. 1982;(22):486–488.

Davis WA, Davis TM, Bruce DG. Predictors of first stroke in diabetes: the Fremantle diabetes study. Diabet Med. 2005; 22:551–3.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.